168 related articles for article (PubMed ID: 6935859)
1. Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentration.
Tomson T; Tybring G; Bertilsson L; Ekbom K; Rane A
Ups J Med Sci Suppl; 1980; 31():45-6. PubMed ID: 6935859
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration.
Tomson T; Tybring G; Bertilsson L; Ekbom K; Rane A
Arch Neurol; 1980 Nov; 37(11):699-703. PubMed ID: 7436811
[TBL] [Abstract][Full Text] [Related]
4. [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].
Cottencin O; Regnaut N; Thévenon-Gignac C; Thomas P; Goudemand M; Debruille C; Robert H
Encephale; 1995; 21(2):141-5. PubMed ID: 7781585
[TBL] [Abstract][Full Text] [Related]
5. Laser evoked potentials and carbamazepine in epileptic patients.
Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G
Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072
[TBL] [Abstract][Full Text] [Related]
6. Trigeminal neuralgia: time course of pain in relation to carbamazepine dosing.
Tomson T; Ekbom K
Cephalalgia; 1981 Jun; 1(2):91-7. PubMed ID: 7346177
[TBL] [Abstract][Full Text] [Related]
7. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
8. [Use of carbamazepine in trigeminal neuralgia].
Puzin Mn; Martynova LA; Sharov MN; Zherdev VP; Starose'lskaia IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(6):105-8. PubMed ID: 2675510
[TBL] [Abstract][Full Text] [Related]
9. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
[TBL] [Abstract][Full Text] [Related]
10. Interaction between carbamazepine and propoxyphene in man.
Dam M; Kristensen CB; Hansen BS; Christiansen J
Acta Neurol Scand; 1977 Dec; 56(6):603-7. PubMed ID: 605781
[TBL] [Abstract][Full Text] [Related]
11. Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules.
Garnett WR; McLean AM; Zhang Y; Clausen S; Tulloch SJ
Curr Med Res Opin; 2003; 19(6):519-25. PubMed ID: 14594524
[TBL] [Abstract][Full Text] [Related]
12. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.
Di Stefano G; La Cesa S; Truini A; Cruccu G
J Headache Pain; 2014 Jun; 15(1):34. PubMed ID: 24912658
[TBL] [Abstract][Full Text] [Related]
13. Is carbamazepine less effective in the treatment of trigeminal neuralgia when prescribed by oral and maxillofacial surgeons?
Stajcic Z; Todorovic L
Anesth Prog; 1997; 44(2):55-8. PubMed ID: 9481961
[TBL] [Abstract][Full Text] [Related]
14. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up.
Fromm GH; Terrence CF; Chattha AS
Ann Neurol; 1984 Mar; 15(3):240-4. PubMed ID: 6372646
[TBL] [Abstract][Full Text] [Related]
15. Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.
Kanarkowski R; Rybakowski J; Lehmann W; Matkowski K
Pol J Pharmacol Pharm; 1991; 43(6):479-85. PubMed ID: 1821043
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal reaction of carbamazepine after neurovascular decompression for trigeminal neuralgia: a preliminary study.
Chen MJ; Zhang WJ; Guo ZL; Zhang WH; Chai Y; Li YW
J Neurol Sci; 2014 Mar; 338(1-2):43-5. PubMed ID: 24387898
[TBL] [Abstract][Full Text] [Related]
17. Effects of carbamazepine/oxycodone coadministration in the treatment of trigeminal neuralgia.
Siniscalchi A; Gallelli L; Avenoso T; Squillace A; De Sarro G
Ann Pharmacother; 2011 Jun; 45(6):e33. PubMed ID: 21652789
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine.
Shaikh S; Yaacob HB; Abd Rahman RB
J Chin Med Assoc; 2011 Jun; 74(6):243-9. PubMed ID: 21621166
[TBL] [Abstract][Full Text] [Related]
19. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
Konsil J; Dechasathian S; Mason DH; Stevens RE
J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
[TBL] [Abstract][Full Text] [Related]
20. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
